1 / 9

BEN / MAL PIGMENTTUMÖRER (MIKAEL KLINKER NOVEMBER 2012)

BEN / MAL PIGMENTTUMÖRER (MIKAEL KLINKER NOVEMBER 2012). MELANOMPREVENTION. Primärprevention (solvanor) Sekundärprevention (tidig diagnostik och behandling). MALIGNT MELANOM. In situ melanom Lentigo maligna Superficial spreading melanoma Nodulärt melanom Lentiginöst acralt melanom.

orrin
Télécharger la présentation

BEN / MAL PIGMENTTUMÖRER (MIKAEL KLINKER NOVEMBER 2012)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. BEN / MAL PIGMENTTUMÖRER(MIKAEL KLINKER NOVEMBER 2012)

  2. MELANOMPREVENTION • Primärprevention (solvanor) • Sekundärprevention (tidig diagnostik och behandling)

  3. MALIGNT MELANOM • In situ melanom • Lentigo maligna • Superficial spreading melanoma • Nodulärt melanom • Lentiginöst acralt melanom

  4. MALIGNT MELANOMBEHANDLING - 1 Kirurgi! Tumörtjocklek (Vårdprogran) In situ – 3 mm marginal < 1 mm – 10 mm marginal ≥ 1 mm – 20 mm marginal + SN-biopsi Uppföljning

  5. MALIGNT MELANOMBEHANDLING - 2 Lentigo maligna - Bucky Spridd sjukdom - Kir klin - Onk klin • Cytostatika • Strålning • Nya behandlingar (Vemurafenib,BRAF-hämmare)

  6. MALIGNT MELANOM • Tumörtjocklek ‹ 1,0 mm › 98 % 5-årsöverlevnad • Tumörtjocklek › 4,0 mm ca 40 % 5-årsöverlevnad

  7. MALIGNT MELANOM 10-års-överlevnad <1,0 mm 95% >8 mm 30%

More Related